U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

POMIFERIN

MORE DETAILS

74YIS40APM

Status:
Possibly Marketed Outside US
Source:
Dekangling by Shenzhen Deyintang Biotechnology Co., Ltd.
(2022)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d884dd7b-fc23-d6d7-e053-2a95a90af9f1
First approved in 2022
Source:
Dekangling by Shenzhen Deyintang Biotechnology Co., Ltd.
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d884dd7b-fc23-d6d7-e053-2a95a90af9f1
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Carbonic anhydrase 2
5
Carbonic anhydrase 1
3
histone deacetylase
1
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966